Package 62135-663-59

Brand: tavaborole

Generic: tavaborole
NDC Package

Package Facts

Identity

Package NDC 62135-663-59
Digits Only 6213566359
Product NDC 62135-663
Description

10 mL in 1 BOTTLE, DROPPER (62135-663-59)

Marketing

Marketing Status
Marketed Since 2023-09-08
Brand tavaborole
Generic tavaborole
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "056ba459-06c7-c5c1-e063-6394a90a54bc", "openfda": {"nui": ["N0000191279", "N0000000150", "M0002832"], "upc": ["0362135663599"], "unii": ["K124A4EUQ3"], "rxcui": ["1543177"], "spl_set_id": ["7fe75d38-80a0-444e-84bc-4087b45a791e"], "pharm_class_cs": ["Boron Compounds [CS]"], "pharm_class_epc": ["Oxaborole Antifungal [EPC]"], "pharm_class_moa": ["Protein Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 mL in 1 BOTTLE, DROPPER (62135-663-59)", "package_ndc": "62135-663-59", "marketing_start_date": "20230908"}], "brand_name": "Tavaborole", "product_id": "62135-663_056ba459-06c7-c5c1-e063-6394a90a54bc", "dosage_form": "SOLUTION", "pharm_class": ["Boron Compounds [CS]", "Oxaborole Antifungal [EPC]", "Protein Synthesis Inhibitors [MoA]"], "product_ndc": "62135-663", "generic_name": "Tavaborole", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tavaborole", "active_ingredients": [{"name": "TAVABOROLE", "strength": "43.5 mg/mL"}], "application_number": "ANDA211963", "marketing_category": "ANDA", "marketing_start_date": "20210203", "listing_expiration_date": "20261231"}